Who
Elizabeth Faust
Director
Company insider
Files Form 4 as: Director, Biomea Fusion; VP Medical Affairs, Pharmacyclics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 14 Mar 2013
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —196,299 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —196,299 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,970 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,025 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,989 at $0.00 | filing |
| 22 Jun 2022filed 24 Jun 2022 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,755 at $0.00 | filing |
| 31 Oct 2013filed 6 Nov 2013 | Pharmacyclics | SEC FORM 4 Code J | $21K327 at $64.81 | filing |
| 9 Jul 2013filed 10 Jul 2013 | Pharmacyclicsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 14 Mar 2013filed 14 Mar 2013 | Pharmacyclicsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.